Nunn Jason Raleigh — SEC insider filings

SEC reporting owner CIK 1444319. 18 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2021-06-02 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Zenas BioPharma, Inc. (ZBIO)Director43 legs · 945,510 sh · $16,199,986—7
Regulus Therapeutics Inc. (RGLS)Director8——16
Addex Therapeutics Ltd. (ADXN)Director2——5
TREVENA INC (TRVN)Director4——4

Insider filings — Nunn Jason Raleigh

FiledFormIssuerReported transactionsSource
2026-11-134Addex Therapeutics Ltd. (ADXN)Grant/award (A): 942,854 (derivative) @ $0EDGAR
2026-09-044Addex Therapeutics Ltd. (ADXN)Disposition to issuer (D): 219,561 @ $0 · Grant/award (A): 219,561 @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-174Zenas BioPharma, Inc. (ZBIO)Grant/award (A): 18,500 (derivative) @ $0EDGAR
2025-10-144Zenas BioPharma, Inc. (ZBIO)Purchase (P): 63,158 @ $19EDGAR
2025-06-274Regulus Therapeutics Inc. (RGLS)Disposition to issuer (D): 62,500 · Disposition to issuer (D): 4,650 (derivative) · Disposition to issuer (D): 2,325 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +3 moreEDGAR
2025-06-124Zenas BioPharma, Inc. (ZBIO)Grant/award (A): 18,500 (derivative) @ $0EDGAR
2025-04-304Regulus Therapeutics Inc. (RGLS)Grant/award (A): 62,500 @ $0EDGAR
2024-09-164Zenas BioPharma, Inc. (ZBIO)Conversion (C): 1,505,388 · Purchase (P): 441,176 @ $17 · Conversion (C): 669,061 · Purchase (P): 441,176 @ $17 · Grant/award (A): 37,000 (derivative) @ $0 · Conversion (C): 13,071,439 (derivative) · +1 moreEDGAR
2024-06-144TREVENA INC (TRVN)Grant/award (A): 13,700 (derivative) @ $0EDGAR
2024-05-214Regulus Therapeutics Inc. (RGLS)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2024-05-174Regulus Therapeutics Inc. (RGLS)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-08-144Regulus Therapeutics Inc. (RGLS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2023-06-204TREVENA INC (TRVN)Grant/award (A): 13,700 (derivative) @ $0EDGAR
2023-06-134Regulus Therapeutics Inc. (RGLS)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-06-134TREVENA INC (TRVN)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-06-104Regulus Therapeutics Inc. (RGLS)Grant/award (A): 90,000 (derivative) @ $0EDGAR
2021-06-154Regulus Therapeutics Inc. (RGLS)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-024TREVENA INC (TRVN)Grant/award (A): 68,577 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1444319 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs